Decoy Therapeutics Inc. (DCOY)

Stammdaten

Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Cambridge, MA.

Unternehmen & Branche

NameDecoy Therapeutics Inc.
TickerDCOY
CIK0001615219
BoerseUS
SektorHealthcare
IndustrieBiotechnology

Wertpapier & Kennzahlen

CUSIP
ISIN
TypCommon Stock
Marktkapitalisierung3,0 Mio. USD
Beta0,37
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K-12,518,480-129.1011,056,7075,888,969
2025-09-3010-Q-873,467-1.816,097,0324,248,065
2025-06-3010-Q-957,825-0.451,392,778-829,724
2025-03-3110-Q-1,709,533-1.032,339,39261,866
2024-12-3110-K-5,575,777-69.543,022,9741,511,695
2024-09-3010-Q-972,121-11.383,859,1642,924,583
2024-06-3010-Q-1,424,433-2.373,553,8222,375,353
2024-03-3110-Q-1,715,290-3.274,883,6593,649,538
2023-12-3110-K-12,542,693-30.746,586,5235,287,282
2023-09-3010-Q-2,442,816-5.218,404,2286,083,703
2023-06-3010-Q-3,877,308-11.4512,055,2988,413,802
2023-03-3110-Q0-5,340,773-2.2310,055,1595,558,861
2022-12-3110-K0-31,607,956-14.8814,650,79910,384,608
2022-09-3010-Q0-14,409,457-6.4119,722,98316,612,536
2022-06-3010-Q0-4,718,338-2.2033,653,98430,884,129
2022-03-3110-Q0-6,109,225-3.3035,507,90433,415,563
2021-12-3110-K1,840,216-12,768,238-7.7240,833,86838,722,985
2021-09-3010-Q0-3,737,100-2.0944,263,00742,650,715
2021-06-3010-Q571,387-3,074,369-0.0747,404,76545,851,130
2021-03-3110-Q1,268,829-1,851,896-0.0650,767,52248,778,043

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.

Hinweis

Erweitert ×